September 17th, 2012
Selections from Richard Lehman’s Literature Review: September 17th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include surgical vs. lifestyle treatment for type-2 diabetes, omega-3 fatty-acid supplementation and the risk for major CVD events, FAME 2, using high-sensitivity cardiac troponin T for one-hour rule-out or rule-in of acute MI, and the timing of acute MI in patients having total hip or knee replacement.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?